$2.15M Private Placement Bolsters Milestone Scientific’s Balance Sheet — Milestone Scientific Inc.

Event summary

Milestone Scientific closed a $2.15M private placement of common stock and warrants on April 20, 2026.
The deal included 7,962,963 units priced at $0.27 per unit, with potential for an additional $2.69M if cash warrants are exercised.
$150,000 of the offering was purchased by directors and officers on the same terms as other investors.
No placement agent or fees were involved in the transaction.

The big picture

Milestone Scientific’s $2.15M private placement strengthens its financial position amid growing demand for its painless injection technologies. The deal, backed by long-term investors and board members, underscores confidence in the company’s strategic direction. This funding will be critical as Milestone scales operations in a competitive medical device market.

What we're watching

Execution Risk: How Milestone Scientific will allocate the $2.15M to scale sales, inventory, and digital marketing while maintaining cost discipline.
Investor Confidence: Whether long-term investor participation signals sustained belief in the company’s technology and strategic direction.
Market Demand: The pace at which increasing demand for Milestone Scientific’s product platforms will translate into revenue growth.